Keeping Track: Nucala, Genvoya Approved; New Breakthrough Claims For Daiichi Sankyo, Merck Oncologics

 
• By Bridget Silverman

The latest drug development news and highlights from our FDA Performance Tracker.

More from Approvals

More from Product Reviews